Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 517 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Uzyskanie certyfikatu CE-IVDR dla systemu BACTEROMIC z Panelem UNI FAST - Content (PL)
Regulatory Filings Classification · 85% confidence The document is a short current report (“raport bieżący”) in Polish notifying the market about the receipt of a CE-IVDR certificate for the company’s diagnostic system. It contains no financial statements, management changes, or voting results—it is a routine regulatory disclosure. It does not present the full report itself but is an official filing under the market disclosure regime. Therefore, it best fits the Regulatory Filings category.
2026-05-22 Polish
Wykaz zmian Statutu
Governance Information Classification · 85% confidence The document is an annex to a current report detailing proposed amendments to the company’s Statute (Articles of Association), specifically changes to governance provisions regarding the Supervisory Board composition and appointment rights. This constitutes governance information about internal rules rather than a management change announcement, earnings release, or proxy solicitation. Therefore it is classified as Governance Information (CGR).
2026-05-21 Polish
Tekst jednolity Statutu
Governance Information Classification · 95% confidence The document is the full text of the company’s Articles of Association (“Statut Spółki”), detailing the internal rules, share capital structure, company organs, and governance provisions. This falls squarely under Governance Information, not merely an announcement or proxy material. Therefore, it should be classified as CGR (Governance Information).
2026-05-21 Polish
SCOPE FLUIDICS SA (18/2026) Rejestracja przez Sąd zmian Statutu Scope Fluidics - Content (PL)
Governance Information Classification · 85% confidence The text is a regulatory current report (Polish ESPI report) announcing that the court has registered amendments to the company’s Statute (articles of association) approved at the AGM. This concerns changes to internal governance rules, not financial results or management appointments. It best fits Governance Information (CGR).
2026-05-21 Polish
Aktualizacja dotycząca półautomatycznej linii produkcyjnej w projekcie BACTEROMIC - Content (PL)
Regulatory Filings Classification · 78% confidence The text is a “raport bieżący” (current report) under Polish corporate rules providing an operational update on installation delays of a production line. It does not present financial statements, dividend notices, management changes, M&A proposals, or any of the specific categories. It is a miscellaneous regulatory announcement, fitting the fallback category of Regulatory Filings (RNS).
2026-05-15 Polish
Skonsolidowany raport kwartalny Grupy Kapitałowej Scope Fluidics S.A. za I kwartał 2026 roku
Interim / Quarterly Report Classification · 90% confidence The document is titled “Raport kwartalny Grupy Kapitałowej Scope Fluidics S.A. za okres 3 miesięcy zakończony 31 marca 2026 roku” and contains consolidated and separate interim financial statements (income statement, balance sheet, cash flows, equity changes, notes) prepared under IFRS for a three-month period. It is a complete quarterly interim report, not merely an announcement. Therefore, it fits the definition of an Interim/Quarterly Report. Q1 2026
2026-05-15 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.